Injectable HIV Prevention Better Than Pills in Two Trials Injectable HIV Prevention Better Than Pills in Two Trials
One trial confirmed the efficacy of CAB LA for transgender women who were also receiving gender-affirming hormone therapy.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 3, 2022 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
No increased risk seen for women using either vaginal estrogen therapy or menopausal hormone therapy after diagnosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2022 Category: Cancer & Oncology Tags: Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
FRIDAY, July 29, 2022 -- In postmenopausal women treated for early-stage estrogen receptor-positive breast cancer, neither vaginal estrogen therapy (VET) nor menopausal hormone therapy (MHT) is associated with an increased risk for recurrence or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2022 Category: Pharmaceuticals Source Type: news

Prostate Cancer Treatment May Raise Heart Risks
WEDNESDAY, July 27, 2022 -- Hormone therapy is a common treatment option for prostate cancer, but it may increase the risk of death from heart disease, especially in older men, a new study finds. Dr. William Dahut, a prostate cancer researcher and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2022 Category: General Medicine Source Type: news

Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer
Hormone therapy did not increase mortality in postmenopausal women treated for early-stage estrogen receptor –positive breast cancer, but there was a recurrence risk with vaginal estrogen therapy.MDedge News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 22, 2022 Category: OBGYN Tags: Hematology-Oncology News Source Type: news

Rising Gestational Diabetes Rates; Updated Hormone Therapy Statement; Insulin Recall
(MedPage Today) -- The U.S. is seeing a rise in gestational diabetes rates, with a 30% jump from 2016 to 2020, the CDC reported. Among 1,050 U.S. adults ages 45 and older, receiving federal rental assistance through project-based housing was tied... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 21, 2022 Category: Endocrinology Source Type: news

NAMS Updates Position Statement on Menopausal Hormone Therapy
WEDNESDAY, July 20, 2022 -- Hormone therapy remains the most effective treatment for vasomotor symptoms (VMS) and genitourinary syndrome of menopause, according to a position statement issued by the North American Menopause Society (NAMS) and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news

Transgender Youth on Hormone Therapy Risk Substantial Bone Loss Transgender Youth on Hormone Therapy Risk Substantial Bone Loss
It appears that bone health deserves attention when adolescents are placed on gender-affirming hormone therapy.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 8, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

After facial feminization surgery, transgender people report better psychosocial health
Key takeaways:A positive step.Gender-affirming surgery is one of the most important procedures for patients with gender dysphoria, researchers say.Quality of life.People who had the surgery reported higher scores in 7 of 11 measures of psychosocial health than those awaiting the procedure.Expanding health coverage.Researchers hope the findings will encourage more U.S. health insurance plans to cover the surgery.A UCLA study offers the first evidence that transgender patients who receive gender-affirming facial feminization surgery reported better mental health after their procedures.Thestudy was published in the journal An...
Source: UCLA Newsroom: Health Sciences - July 6, 2022 Category: Universities & Medical Training Source Type: news

Hormone Replacement Therapy and Breast Cancer: An Overview Hormone Replacement Therapy and Breast Cancer: An Overview
The discordant findings from observational studies and randomized clinical trials affect doctors ' decisions concerning hormone therapy for menopausal women.Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 5, 2022 Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news

Hormone Therapy May Reduce Death, Cancer Risk in Older Women Hormone Therapy May Reduce Death, Cancer Risk in Older Women
Hormone therapy appeared to reduce risks for mortality and several different cancers in postmenopausal women.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 2, 2022 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Hormone Therapy-Related Hot Flashes Tied to Worse Breast Cancer Outcomes
WEDNESDAY, June 29, 2022 -- Adjuvant hormone therapy (AHT)-related hot flashes predict worse breast cancer outcomes among patients in clinical routine practice, according to a study recently published in the Journal of the National Comprehensive... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2022 Category: Pharmaceuticals Source Type: news

Hot Flashes From Hormone Therapy, Poorer Outcomes in Breast Cancer Hot Flashes From Hormone Therapy, Poorer Outcomes in Breast Cancer
Contrary to results from clinical trials, a population-based study found worse disease-free survival among patients who experience adjuvant hormone therapy –related hot flashes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes?
(MedPage Today) -- Hot flashes from adjuvant hormone therapy (AHT) are predictive of worse breast cancer outcomes, according to a Swedish population-based study, a finding that contrasts with previous clinical trial results examining this relationship... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 23, 2022 Category: Hematology Source Type: news

Treatment for people with early breast cancer
Around 4,000 people are set to benefit from a change in treatment for early breast cancer following provisional approval by NICE of abemaciclib in combination with hormone therapy as an option after surgery. (Source: NHS Networks)
Source: NHS Networks - June 23, 2022 Category: UK Health Source Type: news